Overview
PsyDAO is a decentralized collective advancing psychedelic science through community-driven research funding and open intellectual property. The organization promotes progress via distributed coordination, crowdfunding, and collective ownership of IP, ensuring that psychedelic medicine remains accessible to anyone.
PsyDAO uses an Ostrom-inspired governance system with two token classes: $PSYC holders govern research direction, while $PSY holders oversee operations. This dual-token model ensures both scientific rigor and operational accountability.
Research Projects
PsyDAO has awarded 6 grants totaling $280k across science, technology, and culture:
Science:
- Next Gen Empathogens β MDMA prodrug optimization
- eDMT β Endogenous DMT research commons
- Psychedelics X Longevity β LSD vs psilocin comparison study
- DMXE β Dissociative drug development
Technology:
- BeeARD β Multi-agent AI research discovery system
- OPSY β Token-incentivized data collection platform
Culture:
- KeneCafΓ© β E-commerce platform for Amazonian nonprofit, bridging IP and traditional knowledge
